SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William J. Leiby who wrote (567)2/17/1998 6:21:00 PM
From: John McCarthy  Read Replies (2) of 849
 
Hi Bill -

OK - I admit it.

Whats up with the letter of intent verbage below?

Are we launching an air strike or something?

Thanks and Regards,

John

Snippet of P&L Release from today:
==================================================================
'The letter of intent
which we have signed with a recognized leader
in the distribution of diagnostic products to clinical
laboratories is further testament to the clinical potential of the NMP22(R) Test Kit,'' said David L. Corbet, President of
Matritech. ''Matritech's strategy for building market acceptance of the NMP22(R) Test Kit includes targeting key thought
leaders in the field, securing partners for automated systems for testing, expanding U.S. distribution and by continuing to
use our dedicated sales force and educational programs to broadly reach urologists. We continue to increase acceptance
for NMP22(R)) with thought leading institutions such as New York University Medical Center, Boston Medical Center
and University of California, Irvine, and in strengthening distribution channels in Europe and the U.S.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News